nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Vandetanib—thyroid cancer	0.219	0.249	CbGbCtD
Amprenavir—ABCC1—Epirubicin—thyroid cancer	0.151	0.171	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—thyroid cancer	0.0802	0.0911	CbGbCtD
Amprenavir—CYP2B6—Sorafenib—thyroid cancer	0.0622	0.0706	CbGbCtD
Amprenavir—CYP3A5—Sorafenib—thyroid cancer	0.049	0.0556	CbGbCtD
Amprenavir—CYP2C8—Sorafenib—thyroid cancer	0.0471	0.0535	CbGbCtD
Amprenavir—CYP2C19—Sorafenib—thyroid cancer	0.0395	0.0449	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—thyroid cancer	0.0377	0.0429	CbGbCtD
Amprenavir—CYP2C9—Sorafenib—thyroid cancer	0.0329	0.0373	CbGbCtD
Amprenavir—ABCB1—Sorafenib—thyroid cancer	0.0319	0.0362	CbGbCtD
Amprenavir—CYP3A4—Vandetanib—thyroid cancer	0.0317	0.036	CbGbCtD
Amprenavir—CYP2D6—Sorafenib—thyroid cancer	0.03	0.0341	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—thyroid cancer	0.0193	0.022	CbGbCtD
Amprenavir—CYP3A4—Sorafenib—thyroid cancer	0.0191	0.0217	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—thyroid cancer	0.0182	0.0207	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—thyroid cancer	0.0116	0.0132	CbGbCtD
Amprenavir—Amylase increased—Vandetanib—thyroid cancer	0.00682	0.0572	CcSEcCtD
Amprenavir—Amylase increased—Sorafenib—thyroid cancer	0.0046	0.0386	CcSEcCtD
Amprenavir—Nephrolithiasis—Vandetanib—thyroid cancer	0.00404	0.0339	CcSEcCtD
Amprenavir—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.00373	0.0312	CcSEcCtD
Amprenavir—Rhabdomyolysis—Sorafenib—thyroid cancer	0.00248	0.0207	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00208	0.0174	CcSEcCtD
Amprenavir—Opportunistic infection—Epirubicin—thyroid cancer	0.00201	0.0168	CcSEcCtD
Amprenavir—Neutropenia—Vandetanib—thyroid cancer	0.00191	0.016	CcSEcCtD
Amprenavir—Opportunistic infection—Doxorubicin—thyroid cancer	0.00186	0.0156	CcSEcCtD
Amprenavir—Hyperglycaemia—Vandetanib—thyroid cancer	0.00184	0.0154	CcSEcCtD
Amprenavir—Depression—Vandetanib—thyroid cancer	0.00181	0.0152	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0018	0.0151	CcSEcCtD
Amprenavir—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00172	0.0144	CcSEcCtD
Amprenavir—Myositis—Epirubicin—thyroid cancer	0.00165	0.0138	CcSEcCtD
Amprenavir—Erythema multiforme—Vandetanib—thyroid cancer	0.00154	0.0129	CcSEcCtD
Amprenavir—Myositis—Doxorubicin—thyroid cancer	0.00153	0.0128	CcSEcCtD
Amprenavir—Cardiac disorder—Vandetanib—thyroid cancer	0.00151	0.0127	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00143	0.012	CcSEcCtD
Amprenavir—Mental disorder—Vandetanib—thyroid cancer	0.00143	0.012	CcSEcCtD
Amprenavir—Malnutrition—Vandetanib—thyroid cancer	0.00142	0.0119	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.0014	0.0118	CcSEcCtD
Amprenavir—Transaminases increased—Epirubicin—thyroid cancer	0.00133	0.0112	CcSEcCtD
Amprenavir—Tremor—Vandetanib—thyroid cancer	0.00133	0.0111	CcSEcCtD
Amprenavir—Abdominal discomfort—Sorafenib—thyroid cancer	0.00132	0.011	CcSEcCtD
Amprenavir—Neutropenia—Sorafenib—thyroid cancer	0.00129	0.0108	CcSEcCtD
Amprenavir—Transaminases increased—Doxorubicin—thyroid cancer	0.00123	0.0103	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00122	0.0102	CcSEcCtD
Amprenavir—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00121	0.0101	CcSEcCtD
Amprenavir—Myocardial infarction—Sorafenib—thyroid cancer	0.0012	0.0101	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.0012	0.0101	CcSEcCtD
Amprenavir—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00116	0.00971	CcSEcCtD
Amprenavir—Nervous system disorder—Vandetanib—thyroid cancer	0.00114	0.00952	CcSEcCtD
Amprenavir—Skin disorder—Vandetanib—thyroid cancer	0.00113	0.00943	CcSEcCtD
Amprenavir—Connective tissue disorder—Sorafenib—thyroid cancer	0.00108	0.00906	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00106	0.00885	CcSEcCtD
Amprenavir—Paraesthesia—Vandetanib—thyroid cancer	0.00104	0.00872	CcSEcCtD
Amprenavir—Erythema multiforme—Sorafenib—thyroid cancer	0.00104	0.00872	CcSEcCtD
Amprenavir—Cardiac disorder—Sorafenib—thyroid cancer	0.00102	0.00856	CcSEcCtD
Amprenavir—Decreased appetite—Vandetanib—thyroid cancer	0.00101	0.00844	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.001	0.00838	CcSEcCtD
Amprenavir—Fatigue—Vandetanib—thyroid cancer	0.000999	0.00837	CcSEcCtD
Amprenavir—Mental disorder—Sorafenib—thyroid cancer	0.000964	0.00808	CcSEcCtD
Amprenavir—Malnutrition—Sorafenib—thyroid cancer	0.000958	0.00803	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000948	0.00794	CcSEcCtD
Amprenavir—Abdominal pain—Vandetanib—thyroid cancer	0.000916	0.00768	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.000891	0.00746	CcSEcCtD
Amprenavir—Angioedema—Sorafenib—thyroid cancer	0.000875	0.00733	CcSEcCtD
Amprenavir—Inflammation—Epirubicin—thyroid cancer	0.000835	0.00699	CcSEcCtD
Amprenavir—Asthenia—Vandetanib—thyroid cancer	0.000832	0.00697	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.000824	0.0069	CcSEcCtD
Amprenavir—Pruritus—Vandetanib—thyroid cancer	0.00082	0.00687	CcSEcCtD
Amprenavir—Myalgia—Sorafenib—thyroid cancer	0.000816	0.00683	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00081	0.00679	CcSEcCtD
Amprenavir—Diarrhoea—Vandetanib—thyroid cancer	0.000793	0.00664	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—thyroid cancer	0.000773	0.00647	CcSEcCtD
Amprenavir—Nervous system disorder—Sorafenib—thyroid cancer	0.000767	0.00642	CcSEcCtD
Amprenavir—Skin disorder—Sorafenib—thyroid cancer	0.000759	0.00636	CcSEcCtD
Amprenavir—Anorexia—Sorafenib—thyroid cancer	0.000745	0.00624	CcSEcCtD
Amprenavir—Vomiting—Vandetanib—thyroid cancer	0.000737	0.00617	CcSEcCtD
Amprenavir—Rash—Vandetanib—thyroid cancer	0.000731	0.00612	CcSEcCtD
Amprenavir—Dermatitis—Vandetanib—thyroid cancer	0.00073	0.00612	CcSEcCtD
Amprenavir—Headache—Vandetanib—thyroid cancer	0.000726	0.00608	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000712	0.00597	CcSEcCtD
Amprenavir—Nausea—Vandetanib—thyroid cancer	0.000689	0.00577	CcSEcCtD
Amprenavir—Decreased appetite—Sorafenib—thyroid cancer	0.00068	0.00569	CcSEcCtD
Amprenavir—Diabetes mellitus—Epirubicin—thyroid cancer	0.000676	0.00566	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000675	0.00565	CcSEcCtD
Amprenavir—Fatigue—Sorafenib—thyroid cancer	0.000674	0.00565	CcSEcCtD
Amprenavir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000639	0.00536	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000625	0.00524	CcSEcCtD
Amprenavir—Abdominal pain—Sorafenib—thyroid cancer	0.000618	0.00518	CcSEcCtD
Amprenavir—Asthenia—Sorafenib—thyroid cancer	0.000561	0.0047	CcSEcCtD
Amprenavir—Pruritus—Sorafenib—thyroid cancer	0.000553	0.00463	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—thyroid cancer	0.000543	0.00455	CcSEcCtD
Amprenavir—Diarrhoea—Sorafenib—thyroid cancer	0.000535	0.00448	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000529	0.00444	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000519	0.00434	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000502	0.00421	CcSEcCtD
Amprenavir—Vomiting—Sorafenib—thyroid cancer	0.000497	0.00416	CcSEcCtD
Amprenavir—Rash—Sorafenib—thyroid cancer	0.000493	0.00413	CcSEcCtD
Amprenavir—Dermatitis—Sorafenib—thyroid cancer	0.000493	0.00413	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00049	0.0041	CcSEcCtD
Amprenavir—Headache—Sorafenib—thyroid cancer	0.00049	0.0041	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00048	0.00402	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—thyroid cancer	0.000475	0.00398	CcSEcCtD
Amprenavir—Nausea—Sorafenib—thyroid cancer	0.000464	0.00389	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—thyroid cancer	0.000458	0.00384	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000449	0.00376	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—thyroid cancer	0.00044	0.00368	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000429	0.00359	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000424	0.00355	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000416	0.00348	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—thyroid cancer	0.0004	0.00335	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000396	0.00332	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—thyroid cancer	0.000385	0.00322	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—thyroid cancer	0.000377	0.00316	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00037	0.0031	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—thyroid cancer	0.000356	0.00299	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—thyroid cancer	0.000356	0.00298	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—thyroid cancer	0.000354	0.00297	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—thyroid cancer	0.000349	0.00293	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—thyroid cancer	0.000349	0.00292	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—thyroid cancer	0.00033	0.00276	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—thyroid cancer	0.000328	0.00274	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—thyroid cancer	0.000323	0.0027	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—thyroid cancer	0.000301	0.00253	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000299	0.00251	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—thyroid cancer	0.000298	0.00249	CcSEcCtD
Amprenavir—Nervous system disorder—Epirubicin—thyroid cancer	0.000283	0.00237	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—thyroid cancer	0.000281	0.00235	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—thyroid cancer	0.000279	0.00234	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000277	0.00232	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—thyroid cancer	0.000276	0.00231	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—thyroid cancer	0.000275	0.00231	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000263	0.00221	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—thyroid cancer	0.000262	0.0022	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—thyroid cancer	0.00026	0.00218	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—thyroid cancer	0.000259	0.00217	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—thyroid cancer	0.000255	0.00214	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—thyroid cancer	0.000251	0.0021	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000249	0.00209	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—thyroid cancer	0.000249	0.00209	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000244	0.00204	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—thyroid cancer	0.00024	0.00201	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000236	0.00198	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—thyroid cancer	0.000232	0.00195	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000231	0.00193	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—thyroid cancer	0.000231	0.00193	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—thyroid cancer	0.000228	0.00191	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000219	0.00183	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—thyroid cancer	0.000211	0.00177	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—thyroid cancer	0.000207	0.00174	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—thyroid cancer	0.000204	0.00171	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—thyroid cancer	0.000198	0.00166	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—thyroid cancer	0.000192	0.00161	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—thyroid cancer	0.000189	0.00158	CcSEcCtD
Amprenavir—Vomiting—Epirubicin—thyroid cancer	0.000184	0.00154	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—thyroid cancer	0.000183	0.00153	CcSEcCtD
Amprenavir—Rash—Epirubicin—thyroid cancer	0.000182	0.00153	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—thyroid cancer	0.000182	0.00152	CcSEcCtD
Amprenavir—Headache—Epirubicin—thyroid cancer	0.000181	0.00152	CcSEcCtD
Amprenavir—Nausea—Epirubicin—thyroid cancer	0.000172	0.00144	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—thyroid cancer	0.00017	0.00142	CcSEcCtD
Amprenavir—Rash—Doxorubicin—thyroid cancer	0.000169	0.00141	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—thyroid cancer	0.000168	0.00141	CcSEcCtD
Amprenavir—Headache—Doxorubicin—thyroid cancer	0.000168	0.0014	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—thyroid cancer	0.000159	0.00133	CcSEcCtD
